Company: ZVRA
Filing Date: 2025-04-07
Form Type: DEFA14A
Source: 0001193125-25-074700
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-07
Form: DEFA14A
Chunk 2
---
2024, which was filed with the SEC on March 12, 2025 and under the headings “Proposal 1: Election of Directors,” “Executive Officers,”
“Security Ownership of Certain Beneficial Owners and Management” and “Executive Compensation,” and “Director Compensation” in Zevra’s definitive proxy statement on Schedule 14A for its annual meeting of stockholders held in 2024, which was filed with the SEC on April
3, 2024. Changes in the holdings of our directors and executive officers of Zevra securities that were reported in such definitive proxy statement are reflected in the following Forms 3 and Forms 4 filed with the SEC by the persons and on the dates noted:
a Form 3 filed with the SEC by Rahsaan W. Thompson (June25, 2024), a Form 3 filed by Adrian W. Quartel (March27, 2025), and the following Forms 4: Thomas Anderson (May15, 2024), Alvin Shih (May15, 2024), Corey M. Watton (May15, 2024), Douglas W. Calder (May15, 2024), Tamara A. Favorito (May15, 2024), Wendy L. Dixon (May15, 2024), John B. Bode (May15, 2024), Rahsaan W. Thompson (June25, 2024), John B. Bode (July15, 2024), Thomas Anderson (July16, 2024), R. LaDuane Clifton (July17, 2024), Corey M. Watton (October16, 2024), Neil F. McFarlane (February3, 2025), R. LaDuane Clifton (February3, 2025), Joshua Schafer (February3, 2025), Rahsaan W. Thompson (February3, 2025), Neil F. McFarlane (February10, 2025), Neil F. McFarlane (February14, 2025), R. LaDuane Clifton (February14, 2025), Joshua Schafer (February14, 2025), John B. Bode (March21, 2025), Adrian W. Quartel (March27, 2025) and Corey M. Watton (March 31, 2025).These documents are available free of charge at the SEC’s website at
. Copies of the